ADVANZ Trademark

Trademark Overview


On Friday, May 25, 2018, a trademark application was filed for ADVANZ with the United States Patent and Trademark Office. The USPTO has given the ADVANZ trademark a serial number of 87936981. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 5, 2022. This trademark is owned by Concordia International RX (UK) Limited. The ADVANZ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and i...

Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer
advanz

General Information


Serial Number87936981
Word MarkADVANZ
Filing DateFriday, May 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2018

Trademark Statements


Goods and ServicesA full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations
Goods and ServicesMedical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, June 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, June 3, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADVANZ PHARMA SERVICES (UK) LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressLONDON EC4N7BL
GB

Party NameConcordia International RX (UK) Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC4N7BL
GB

Party NameConcordia International RX (UK) Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4N7BL
GB

Trademark Events


Event DateEvent Description
Monday, December 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 3, 2022SOU EXTENSION 5 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 5 FILED
Tuesday, May 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 27, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 14, 2021SOU EXTENSION 4 GRANTED
Thursday, October 14, 2021SOU EXTENSION 4 FILED
Thursday, October 14, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 22, 2021SOU EXTENSION 3 GRANTED
Thursday, April 22, 2021SOU EXTENSION 3 FILED
Thursday, April 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, October 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 27, 2020SOU EXTENSION 2 GRANTED
Tuesday, October 27, 2020SOU EXTENSION 2 FILED
Tuesday, October 27, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020SOU EXTENSION 1 GRANTED
Monday, April 20, 2020SOU EXTENSION 1 FILED
Monday, April 20, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2020DATA MODIFICATION COMPLETED
Tuesday, October 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 18, 2019TTAB RELEASE CASE TO TRADEMARKS
Wednesday, September 18, 2019OPPOSITION TERMINATED NO. 999999
Wednesday, September 18, 2019OPPOSITION DISMISSED NO. 999999
Friday, June 21, 2019OPPOSITION INSTITUTED NO. 999999
Wednesday, February 6, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, January 31, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, January 30, 2019ASSIGNED TO PETITION STAFF
Thursday, January 24, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 22, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 16, 2018ASSIGNED TO LIE
Wednesday, October 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 31, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, October 31, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 31, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, October 31, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, October 26, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 2, 2018WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, September 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 15, 2018ASSIGNED TO EXAMINER
Sunday, June 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 29, 2018NEW APPLICATION ENTERED